Gosset Ownership
Private
Employees
~21
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Solvotrin Therapeutics General Information
Active Iron is clinically proven to be significantly better absorbed than the gold standard ferrous sulfate while avoiding negative gastrointestinal side effects commonly associated with oral iron[4][7].
Contact Information
Primary Industry
Biotech
Corporate Office
Cork, Cork
Ireland
Ireland
Drug Pipeline
Active Iron
CommercialKey Partnerships
Norwell Consumer Healthcare (Canada), Shanghai Fosun Pharmaceutical (China)
Solvotrin Therapeutics Funding
No funding data available
To view Solvotrin Therapeutics's complete valuation and funding history, request access »